Regis Healthcare Limited (ASX:REG)
Australia · Delayed Price · Currency is AUD 4.710
-0.090 (-1.88%)
Sep 18, 2026, 4:10 PM AEST
Regis Healthcare Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 1,425 | 1,962 | 2,362 | 1,313 | 668 | 557 | |
Market Cap Growth | -47.80% | -16.91% | 79.94% | 96.48% | 20.03% | -5.11% |
Enterprise Value | 1,255 | 1,769 | 2,186 | 1,299 | 740 | 624 |
Last Close Price | 4.71 | 6.36 | 7.50 | 4.06 | 1.98 | 1.61 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 25.63 | 35.24 | 48.25 | - | - | - |
Forward PE | 24.68 | 29.01 | 39.08 | 31.53 | 27.24 | 18.23 |
PS Ratio | 1.05 | 1.45 | 2.03 | 1.29 | 0.86 | 0.77 |
PB Ratio | -117.44 | -161.76 | -141.22 | -57.35 | 17.40 | 7.04 |
P/FCF Ratio | 7.33 | 10.10 | 10.75 | 7.04 | 12.43 | 8.23 |
P/OCF Ratio | 4.24 | 5.84 | 7.72 | 5.20 | 6.35 | 4.85 |
PEG Ratio | - | 1.32 | 1.38 | 0.72 | 0.72 | 0.68 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 0.93 | 1.31 | 1.88 | 1.28 | 0.95 | 0.86 |
EV/EBITDA Ratio | 9.88 | 14.10 | 20.14 | 15.07 | 13.41 | 12.84 |
EV/EBIT Ratio | 17.74 | 25.01 | 36.42 | - | - | - |
EV/FCF Ratio | 6.46 | 9.11 | 9.95 | 6.96 | 13.77 | 9.23 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | -0.33 | -0.33 | -0.31 | -0.17 | 1.85 | 1.43 |
Debt / EBITDA Ratio | 0.03 | 0.03 | 0.05 | 0.04 | 1.26 | 2.29 |
Debt / FCF Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 1.32 | 1.68 |
Net Debt / Equity Ratio | 14.00 | 14.00 | 11.20 | 2.67 | 0.25 | 1.38 |
Net Debt / EBITDA Ratio | -1.35 | -1.35 | -1.73 | -0.71 | 0.18 | 2.25 |
Net Debt / FCF Ratio | -0.87 | -0.87 | -0.85 | -0.33 | 0.18 | 1.62 |
Asset Turnover | 0.57 | 0.57 | 0.59 | 0.58 | 0.46 | 0.42 |
Inventory Turnover | - | - | - | - | 184.80 | 127.94 |
Quick Ratio | 0.08 | 0.08 | 0.11 | 0.05 | 0.07 | 0.02 |
Current Ratio | 0.08 | 0.08 | 0.11 | 0.06 | 0.07 | 0.03 |
Return on Equity (ROE) | - | - | - | -276.16% | -48.47% | -35.12% |
Return on Assets (ROA) | 1.88% | 1.88% | 1.92% | -1.47% | -2.58% | -1.93% |
Return on Invested Capital (ROIC) | 44392.73% | - | - | -242.72% | -59.15% | -22.32% |
Return on Capital Employed (ROCE) | 66734.90% | 66734.90% | -1030.30% | 282.90% | -53.70% | -24.10% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 3.91% | 2.84% | 2.07% | -1.63% | -4.26% | -6.97% |
FCF Yield | 13.63% | 9.90% | 9.30% | 14.21% | 8.04% | 12.15% |
Dividend Yield | 3.99% | 2.89% | 2.16% | 3.18% | 4.79% | 3.63% |
Payout Ratio | 100.11% | 92.86% | 90.62% | - | - | - |
Buyback Yield / Dilution | 0.30% | 0.30% | -0.93% | -0.05% | -0.02% | 0.01% |
Total Shareholder Return | 4.30% | 3.20% | 1.23% | 3.13% | 4.77% | 3.65% |